Background: In the early 1970s the existence of an optimal hematocrit or Hb concentration under normovolemic or isovolemic hemodilution as well as hemoconcentration was found experimentally in vivo for animals. This was highly conform to a theoretically predicted optimum in that range. Thus, the maximum of systemic oxygen availability as the product of cardiac output and arterial oxygen content at about 110% relative to the control coincided with the hematocrit value of about 30%, corresponding to a Hb concentration of about 10 g/dl. As a result of decreased blood viscosity, the cardiac output increased more than necessary for compensation. A few years later, other authors could not reproduce these results and additionally mentioned that the conclusions were not compatible with their experimental data. Aim and Sources: Relevant literature data of the last 35 years were analyzed critically provided that they comprised quantitative data concerning the oxygen availability as a function of oxygen or Hb concentration or that these values could be derived in part from the published data of hematocrit. Results: As a result of critical analysis of a great number of relevant literature data, the above statement now is obsolete: During normovolemic hemodilution as well as hemoconcentration, the maximum of oxygen availability is reached at the physiological hematocrit and Hb concentration, respectively, decreasing at both sides. Conclusion: Only one group has published an optimal hematocrit of 30%, a result which is not compatible with the data they obtained experimentally. Therefore, this revised conclusion must be interpreted as a farewell to the fallacy of an optimal hematocrit of 30%.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.